These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 31181209)

  • 1. IMM-H007 improves heart function via reducing cardiac fibrosis.
    Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
    Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMM-H007 attenuates isoprenaline-induced cardiac fibrosis through targeting TGFβ1 signaling pathway.
    Wang SX; Feng YN; Feng S; Wu JM; Zhang M; Xu WL; Zhang YY; Zhu HB; Xiao H; Dong ED
    Acta Pharmacol Sin; 2022 Oct; 43(10):2542-2549. PubMed ID: 35354962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cordycepin derivative IMM-H007 improves endothelial dysfunction by suppressing vascular inflammation and promoting AMPK-dependent eNOS activation in high-fat diet-fed ApoE knockout mice.
    Wang MJ; Peng XY; Lian ZQ; Zhu HB
    Eur J Pharmacol; 2019 Jun; 852():167-178. PubMed ID: 30826323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts.
    Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL
    Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.
    Zhao L; Mi Y; Guan H; Xu Y; Mei Y
    Eur J Pharmacol; 2016 Jul; 783():33-46. PubMed ID: 27108788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelsolin is an important mediator of Angiotensin II-induced activation of cardiac fibroblasts and fibrosis.
    Jana S; Aujla P; Hu M; Kilic T; Zhabyeyev P; McCulloch CA; Oudit GY; Kassiri Z
    FASEB J; 2021 Oct; 35(10):e21932. PubMed ID: 34549830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.
    Zhang N; Wei WY; Liao HH; Yang Z; Hu C; Wang SS; Deng W; Tang QZ
    J Mol Med (Berl); 2018 Dec; 96(12):1345-1357. PubMed ID: 30341569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [AMP-activated kinase activation inhibits transforming growth factor-β1 production in cardiac fibroblasts via targeting C/EBPβ].
    Xiao H; Piao CS; Chen RF; Zhang YY
    Sheng Li Xue Bao; 2017 Apr; 69(2):123-128. PubMed ID: 28435970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II.
    Ma F; Li Y; Jia L; Han Y; Cheng J; Li H; Qi Y; Du J
    PLoS One; 2012; 7(5):e35144. PubMed ID: 22574112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALDH2 Activation Inhibited Cardiac Fibroblast-to-Myofibroblast Transformation Via the TGF-β1/Smad Signaling Pathway.
    Yuan Q; Cao S; Dong Q; Wang Z; Xu Y; Han Q; Ma J; Wei S; Pang J; Yang F; Zhang R; Liu B; Dai S; Xue L; Wang J; Xue M; Xu T; Zheng W; Xu F; Chen Y; Guo P
    J Cardiovasc Pharmacol; 2019 Apr; 73(4):248-256. PubMed ID: 30801261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin attenuates angiotensin II-induced TGFβ1 expression by targeting hepatocyte nuclear factor-4-α.
    Chen R; Feng Y; Wu J; Song Y; Li H; Shen Q; Li D; Zhang J; Lu Z; Xiao H; Zhang Y
    Br J Pharmacol; 2018 Apr; 175(8):1217-1229. PubMed ID: 28230250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction.
    Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.
    Chen X; Long L; Cheng Y; Chu J; Shen Z; Liu L; Li J; Xie Q; Liu H; Wu M; Chen Y; Peng J; Shen A
    Biomed Pharmacother; 2021 May; 137():111318. PubMed ID: 33556875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart.
    Yao Y; Hu C; Song Q; Li Y; Da X; Yu Y; Li H; Clark IM; Chen Q; Wang QK
    Cardiovasc Res; 2020 Apr; 116(5):956-969. PubMed ID: 31297506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis.
    Meng G; Zhu J; Xiao Y; Huang Z; Zhang Y; Tang X; Xie L; Chen Y; Shao Y; Ferro A; Wang R; Moore PK; Ji Y
    Oxid Med Cell Longev; 2015; 2015():691070. PubMed ID: 26078813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
    Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
    Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
    Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
    J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
    Hermida N; Markl A; Hamelet J; Van Assche T; Vanderper A; Herijgers P; van Bilsen M; Hilfiker-Kleiner D; Noppe G; Beauloye C; Horman S; Balligand JL
    Cardiovasc Res; 2013 Jul; 99(1):44-54. PubMed ID: 23542580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.